Hospitals sue – again – to halt Trump administration’s 340B rebate pilot
The American Hospital Association is challenging a revised drug-discount pilot in court; the legal dispute leaves the program's implementation uncertain.
TL;DR
- The American Hospital Association filed another lawsuit seeking to block the federal 340B rebate pilot.
- The revised model would replace some upfront discounts with rebates after covered entities purchase medicines.
- The case challenges the administration's authority and process; the court has not resolved the new dispute.
The American Hospital Association has sued the federal government again over a pilot that would change how discounts are delivered through the 340B Drug Pricing Program. STAT and Fierce Healthcare reported the new filing on October 9. [1, 2] [1] [2]
Under the pilot model described in the coverage, participating providers would pay for certain medicines and seek rebates afterward, rather than receiving the discount at purchase. The association argues that the agency's revised approach remains legally flawed. [1, 2] [1] [2]
The dispute follows an earlier court challenge that paused a prior version of the pilot. The current case concerns a revised program and its implementation, so the earlier litigation does not by itself determine how the new filing will be decided. [1, 2] [1] [2]
The court's next actions and any effect on the program's timing remain open. The filing presents the hospitals' position; the coverage does not establish a final judicial ruling on the merits of the renewed challenge. [1, 2] [1] [2]
Why it matters
The 340B program shapes drug purchasing and cash flow for participating safety-net providers. A shift from upfront discounts to after-purchase rebates could change administrative and financing burdens, but the legal challenge means the policy's operation remains uncertain.
Editor's note
Describes the lawsuit and parties' positions; no prediction about the court outcome.